Moleculin Biotech, Inc DEFA14A, filed Apr 13, 2023
Moleculin Biotech, Inc. (MBRX)
|
UNITED STATES
SCHEDULE 14A |
|
Filed by the Registrant ☒ |
|
|
Filed by a Party other than the Registrant ☐ |
|
|
Check the appropriate box: |
|
|
☐ Preliminary Proxy Statement |
|
|
☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2) |
|
|
☐ Definitive Proxy Statement |
|
|
☒ Definitive Additional Materials |
|
|
☐ Soliciting Material Pursuant to §240.14a-12 |
|
|
Moleculin Biotech, Inc. (Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
|
|
Payment of Filing Fee (Check the appropriate box): |
|
|
☒ No fee required. |
|
|
☐ Fee paid previously with preliminary materials. |
|
|
☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11 |
|
